62 results on '"carmustine"'
Search Results
2. MINISTRY OF HEALTH, JKN SELANGOR HOSPITAL AMPANG ADMIN/ FINANCE/ MANAGEMENT UNIT invites tenders for Quote the Price of Supplying and Sending Carmustine 100Mg Injection at Ampang Hospital for a Period of Two (2) Years
3. Carmustine Drug Supply 100 Mg Vial
4. Carmustine Medication Supply 100 Mg Vial
5. Procurement Of An Unregistered Cytostatic Drug From The D List Of Drugs For The Needs Of Transplants - Carmustine For The Needs Of The Clinical Center Of Vojvodina
6. Medicinal Products Containing Carmustine - Combined Purchase
7. Medicinal Products Containing Carmustine - Combined Purchase
8. Carmustine, Unregistered Cytostatic, D Drug List
9. RINQUE PHARMA S.A. secures contract for PHARMACY REQUEST Item NA¦1 Carmustine (Injectable) (Code Article 16669)
10. Supply Of Medicines With Active Ingredients Lenalidomide, Oxaliplatin, Pemetrexed, Sunitinib, Vinorelbin For Oral Administration, Tiotopa, Carmustine And Doetxel
11. Supply Of Drugs With Active Ingredients Lenalidomide, Oxaliplatin, Pemetrexed, Sunitinib, Vinorelbine For Oral Administration, Thiotepa, Carmustine And Docetaxel
12. Urtica Sp. z o.o. secures contract for Delivery of Avelumab and Carmustine for the needs of COZL
13. Tramco Sp. z o.o. secures contract for Delivery of Avelumab and Carmustine for the needs of COZL
14. Carmustine 100 Mg Intravenous Injection
15. Supply Of Drugs With Active Ingredients Lenalidomide, Oxaliplatin, Pemetrexed, Sunitinib, Vinorelbine For Oral Administration, Thiotepa, Carmustine And Docetaxel
16. Accord Healthcare Launches Generic Drug for Treating Brain Tumors & Blood Cancers
17. Accord Healthcare Launches Generic Drug for Treating Brain Tumors & Blood Cancers
18. Dr Reddys Laboratories launches Carmustine for Injection in US market
19. Delivery Of Avelumab And Carmustine For Cozl
20. Accord Healthcare Launches Generic Drug for Treating Brain Tumors & Blood Cancers
21. Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
22. Dr. Reddy's launches Carmustine for Injection, USP in US market
23. News Flash:Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
24. Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
25. Global Brain Tumor Drugs Industry Outlook to 2030: Historical & Future Insights Into Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, and Erlotinib
26. Global Brain Tumor Drugs Industry Outlook to 2030: Historical & Future Insights Into Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, and Erlotinib
27. Brain Tumor Drugs Market - Global Growth, Trends And Forecast
28. Dr. Reddy's Laboratories unveils Carmustine for Injection, USP in the US Market
29. Dr. Reddy's Laboratories unveils Carmustine for Injection, USP in the US Market
30. Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib
31. Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib
32. Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib - ResearchAndMarkets.com
33. STI Pharma Announces US Launch of Generic BICNU(r) for Injection
34. STI Pharma Announces US Launch of Generic BICNU for Injection
35. EU Contract Notice: Institute of Hematology and Transfusion Medicine Issues contract notice|solicitation for 'Poland-Warsaw: Pharmaceutical products'
36. Supply Of Drugs (carmustine)
37. Supply Of Parenteral Carmustine (doe) For All Osakidetza Service Organizations And Linked Centers (spain-vitoria-gasteiz: Pharmaceutical Products)
38. Summary of opinion1 (initial authorisation) Carmustine Obvius carmustine
39. EMA|COMP|270019|2018 Inspections, Human Medicines Pharmacovigilance and Committees Division Committee for Orphan Medicinal Products (COMP) meeting report on the review of applications for orphan designation
40. EMEA|H|C|004326 Carmustine Obvius (carmustine) An overview of Carmustine Obvius and why it is authorised in the EU
41. EMA|355631|2018 Public summary of opinion on orphan designation
42. Supply Of Exclusive Medicines: Carmustine 100 Mg, 1 Vial
43. European Medicine Agency new product:Carmustine Obvius
44. European Medicine Agency new product details:Carmustine Obvius
45. Supply Of Exclusive Medicines: Carmustine 100 Mg; 1 Vial
46. **emg** Carmustine For Injection (bicnu) (va-18-00046315) 663-a80077
47. Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib - ResearchAndMarkets.com
48. Bicnu Carmustine 100mg + Dilulent 3ml Sdvosb|Vosb Sources Sought
49. Findings from University of Witwatersrand Broaden Understanding of Carmustine Therapy (AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain)
50. Reports Outline Nitrosourea Compounds Findings from National Chung Cheng University (Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer ...)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.